Advisor Group Holdings, Inc.
- SEC CIK
- 0001677044
- Latest filing
- Aug 14, 2026
CDTX holding history
Cidara Therapeutics, Inc. in every 13F filed by Advisor Group Holdings, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CDTX overviewAll 13F holders of CDTXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −48−100.0% | Sold out | Holders |
| Q4 2025 | 48 | $10.6K | <0.1% | −72−60.0% | Reduced | Holders |
| Q3 2025 | 120 | $11.4K | <0.1% | +120 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −2,632−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q1 2024 | 52,642 | $48.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 52,642 | $41.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 52,642 | $49.6K | <0.1% | +767+1.5% | Added | Holders |
| Q2 2023 | 51,875 | $58.6K | <0.1% | +12,975+33.4% | Added | Holders |
| Q1 2023 | 38,900 | $49.4K | <0.1% | +38,900 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −22,000−100.0% | Sold out | Holders |
| Q3 2022 | 22,000 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 22,000 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 22,000 | $18.0K | <0.1% | −100−0.5% | Reduced | Holders |
| Q4 2021 | 22,100 | $28.0K | <0.1% | +12,100+121.0% | Added | Holders |
| Q3 2021 | 10,000 | $22.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 10,000 | $20.0K | <0.1% | +10,000 | New | Holders |